butenolide has been researched along with Depressive Disorder in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kulkarni, M; Naidoo, D; Pošta, M; Roy, A; Van Staden, J | 1 |
1 other study(ies) available for butenolide and Depressive Disorder
| Article | Year |
|---|---|
Synthesis of potent neuroprotective butenolides based on plant smoke derived 3,4,5-Trimethylfuran-2(5H)-one and 3-methyl-2H-furo[2,3-c]pyrone-2-one.
Topics: 4-Butyrolactone; Acetylcholinesterase; Depressive Disorder; Dose-Response Relationship, Drug; Furans; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Neuroprotective Agents; Pyrans; Structure-Activity Relationship | 2019 |